Early research (Phase 1)Ended earlyNCT02714374What this trial is testingGL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersWho this might be right forSolid Organ Cancers Andrew Lowy 5
Testing effectiveness (Phase 2)Looking for participantsNCT05746208What this trial is testingLenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine TumorsWho this might be right forNeuroendocrine TumorsWell-Differentiated Neuroendocrine CarcinomaHigh Grade Neuroendocrine Carcinoma, Any Site University of California, San Francisco 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT02713269What this trial is testingThermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal CordWho this might be right forMalignant Digestive System NeoplasmMetastatic Head and Neck CarcinomaMetastatic Kidney Carcinoma+10 more M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT05684692What this trial is testingScreening Trial for Pain Relief in Schwannomatosis (STARFISH)Who this might be right forSchwannomatosisSchwannomasPain, Chronic Massachusetts General Hospital 40
Early research (Phase 1)Looking for participantsNCT06889493What this trial is testingSVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)Who this might be right forNeuroendocrine CarcinomaNeuroendocrine Tumors Peter Hosein, MD 36
Early research (Phase 1)Study completedNCT05858736What this trial is testingSafety, PK and Efficacy of AI-061 in Advanced Solid TumorsWho this might be right forMelanomaNon Small Cell Lung CancerHead and Neck Squamous Cell Carcinoma+14 more OncoC4, Inc. 18
Early research (Phase 1)Study completedNCT03517488What this trial is testingXmAb®20717 in Subjects With Selected Advanced Solid TumorsWho this might be right forMelanomaBreast CarcinomaHepatocellular Carcinoma+25 more Xencor, Inc. 150
Early research (Phase 1)Active Not RecruitingNCT05538130What this trial is testingLearn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsWho this might be right forMelanomaGliomaThyroid Cancer+10 more Pfizer 148
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT02132468What this trial is testingA Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated BiomarkersWho this might be right forNeuroendocrine Tumors Mateon Therapeutics 18
Testing effectiveness (Phase 2)Ended earlyNCT05420636What this trial is testingIadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NETWho this might be right forSmall-cell Lung CancerNeuroendocrine Carcinoma Fox Chase Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03333616What this trial is testingNivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary TumorsWho this might be right forGenitourinary CancerAdrenocortical CarcinomaNon-urothelial Bladder+5 more Dana-Farber Cancer Institute 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013What this trial is testingNivolumab and Ipilimumab in Treating Patients With Rare TumorsWho this might be right forAcinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Looking for participantsNCT07115043What this trial is testingInvestigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more AstraZeneca 120
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Not applicableUnknownNCT06343428What this trial is testingDefinition of a Multiparametric Prognostic and Predictive System of Classification of NET G3 PatientsWho this might be right forNeuroendocrine Neoplasm European Institute of Oncology 20
Not applicableLooking for participantsNCT07429851What this trial is testingCompArative Analysis Between, Thymic, pulmonaRy and Pancreatic Well Differentiated High Grade Neuroendocrine TumorsWho this might be right forNeuroendocrine Carcinoma of LungNeuroendocrine Carcinoma of Thymus European Institute of Oncology 34
Early research (Phase 1)Active Not RecruitingNCT04616248What this trial is testingIn Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid TumorsWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8+10 more University of Southern California 14
Large-scale testing (Phase 3)Study completedNCT00002641What this trial is testingSurgery With or Without Chemotherapy in Treating Patients With Soft Tissue SarcomaWho this might be right forEndometrial CancerKidney CancerOvarian Cancer+2 more European Organisation for Research and Treatment of Cancer - EORTC 350
Testing effectiveness (Phase 2)Study completedNCT00193531What this trial is testingPaclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine CarcinomaWho this might be right forNeuroendocrine Carcinoma SCRI Development Innovations, LLC 100